⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28284731 | 1.00 | — | — | |
| SCHEMBL29058293 | 0.83 | — | — | |
| SCHEMBL415287 | 0.83 | — | — | |
| SCHEMBL443387 | 0.83 | — | — | |
| SCHEMBL443388 | 0.83 | — | — | |
| SCHEMBL9015318 | 0.81 | — | — | |
| SCHEMBL9015320 | 0.81 | — | — | |
| SCHEMBL10898674 | 0.78 | — | — | |
| SCHEMBL11497548 | 0.78 | — | — | |
| SCHEMBL27831164 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4153310-B1 | BBETA-15-42 FOR THE TREATMENT OF VIRAL ENDOTHELITIS | F4 PHARMA GMBH (AT) | 2026-02-18 | — | — | EP | disclosed |
| US-20230293640-A1 | COMPOUNDS FOR THE TREATMENT OF ENDOTHELIITIS IN CONTEXT OF VIRALLY CAUSED DISEASES | F4 PHARMA GMBH (AT) | 2023-09-21 | — | — | US | disclosed |
| EP-4153310-A1 | BBETA-15-42 FOR THE TREATMENT OF VIRAL ENDOTHELITIS | F4 Pharma GmbH (AT) | 2023-03-29 | — | — | EP | disclosed |
| CN-105050614-B | Stimulate the peptide with reduced toxicity of Cholesterol Efflux | 加利福尼亚大学董事会 | 2019-04-05 | — | — | CN | disclosed |
| CN-109196004-A | Engineered scaffold for vascularized tissue repair | 加利福尼亚大学董事会 | 2019-01-11 | — | — | CN | disclosed |
| CN-106573031-A | Bi-terminal pegylated integrin-binding peptides and methods of use thereof | 加利福尼亚大学董事会 | 2017-04-19 | — | — | CN | disclosed |
| WO-2008031016-A2 | HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-03-13 | — | — | WO | disclosed |
| EP-0082088-A1 | Derivatives of amino acids and their therapeutic use | Roques, Bernard (FR) | 1983-06-22 | — | — | EP | disclosed |